Biomarkers of leukemia risk: Benzene as a model

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 4, 1998, Pages 937-946

  Smith, Martyn T ^a   Zhang, Luoping ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemical exposure; Children; Chromosome aberrations; Fluorescence in situ hybridization; Genetic susceptibility; Molecular epidemiology; Polymerase chain reaction

Indexed keywords

BENZENE;

ADOLESCENT; ADULT; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME ABERRATION; CONFERENCE PAPER; DISEASE MARKER; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC PREDISPOSITION; HUMAN; LEUKEMIA; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TOXICOLOGY;

EID: 0031657663     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106s4937     Document Type: Conference Paper

References (139)

1. Sawyers CL, Denny CT, Witte ON. Leukemia and the disruption of normal hematopoiesis. Cell 64: 337-350 (1991).
2. Matutes E, Morilla R, Farahat N, Carbonell F, Swansbury J, Dyer M, Catovsky D. Definition of acute biphenotypic leukemia. Haematologica 82: 64-66 (1997).
3. U.S. National Institutes of Health. Leukemia. Rpt no 94-329. Bethesda, MD: National Cancer Institute, 1993.
4. Pui CH, Childhood leukemias. N Engl J Med 332: 1618-1630 (1995).
5. Lichtman MA. Acute myelogenous leukemia. In: Williams Hematology (Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds). New York: McGraw-Hill, 1995;272-298.
6. Jandl JH, ed. Acute myelogenous leukemia. In: Blood: Textbook of Hematology, 2nd Ed. Boston: Little, Brown and Company, 1996;853-901.
7. Mauer AL. Acute lymphocytic leukemia. In: Williams Hematology (Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds). New York: McGraw-Hill, 1995;1004-1016.
8. Schiffer CA, Schimpff SC. Acute leukemia. In: Comprehensive Textbook of Oncology. Vol 2 (Moosa AR, Schimpff SC, Robson MC, eds). Baltimore: Williams & Wilkins, 1991;1203-1211.
9. LSA. Facts about Leukemia, Lymphoma, Hodgkin's Disease and Myeloma. Report. New York: Leukemia Society of America, 1996-1997.
10. Sandler DP, Ross JA. Epidemiology of acute leukemia in children and adults. Semin Oncol 24: 3-16 (1997).
11. Sandier DP, Collman GW. Cytogenetic and environmental factors in the etiology of the acute leukemias in adults. Am J Epidemiol 126: 1017-1032 (1987).
12. Hansen NE, Karle H, Jensen OM. Trends in the incidence of leukemia in Denmark, 1943-77: an epidemiologic study of 14,000 patients. J Natl Cancer Inst 71: 697-701 (1983).
13. Selvin S, Levin LI, Merrill DW, Winkelstein W Jr. Selected epidemiologic observations of cell-specific leukemia mortality in the United States, 1969-1977. Am J Epidemiol 117: 140-152 (1983).
14. Bloomfield CD, Foon KA, Levine EG. Leukemias. In: Medical Oncology (Calabresi P, Schein PS, eds). New York: McGraw-Hill, 1993;459-501.
15. Aul C, Gattermann N, Schneider W. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Br J Haematol 82: 358-367 (1992).
16. Hasle H, Kerndrup G, Jacobsen BB. Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions. Leukemia 9: 1569-1572 (1995).
17. Franchini G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 86: 3619-3639 (1995).
18. Greaves MF. Aetiology of acute leukaemia. Lancet 349: 344-349 (1997).
19. Sawyers CL. Molecular genetics of acute leukaemia. Lancet 349: 196-200 (1997).
20. Shannon KM, Turhan AG, Rogers PC, Kan YW. Evidence implicating heterozygous deletion of chromosome 7 in the pathogenesis of familial leukemia associated with monosomy 7. Genomics 14: 121-125 (1992).
21. Linet MS, Hatch HE, Kleinerman RA, Robison LL, Kaune WT, Friedman DR, Severson RK, Haines CM, Hartsock CT, Niwa S, et al. Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. N Engl J Med 337: 1-7 (1997).
22. Verkasalo PK. Magnetic fields and leukemia - risk for adults living close to power lines. Scand J Work Environ Health 22(Suppl 2): 1-56(1996).
23. Aksoy M. Benzene Carcinogenicity. Boca Raton, FL: CRC Press, 1988.
24. Wong O. Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene. Occup Environ Med 52: 380-384 (1995).
25. Pedersen-Bjergaard J, Philip P. Two different classes of therapy-related and de-novo acute myeloid leukemia? Cancer Genet Cytogenet 55: 119-124 (1991)
26. Poplack DG. Acute lymphoblastic leukemia. In: Principles and Practice of Pediatric Oncology (Pizzo PA, Poplack DG, eds). Philadelphia: J.B. Lippincott, 1993: 431-481.
27. Kazak AE, Barakat LP, Meeske K, Christakis D, Meadows AT, Casey R, Penati B, Stuber ML. Posttraumatic stress, family Functioning, and social support in survivors of childhood leukemia and their mothers and fathers. J Consult Clin Psychol 65: 120-129 (1997).
28. Santesson GG. Uber chronische Vergiftungen mit Steinkohlentheerbenzin; vier Todesfalle. Arch Hyg 31: 336-376 (1897).
29. Le Noir A, Claude J. Sur un case de purpura attribute a l'intoxication par le benzene. Bull Mem Soc Med Hop Paris 3: 1251-1261 (1897).
30. Delote P, Borgomano C. Leucemic aique au cours de l'intoxication benzenique. Sur l'origine toxique de certaines leucemies aigues et leurs relations avec les anemies graves. J Med Lyon 9: 227-233 (1928).
31. Vigliani EC, Saita G. Benzene and leukemia. N Eng J Med 271: 872-876 (1964).
32. Vigliani EC, Forni A. Benzene and leukemia. Environ Res 11: 122-127 (1976).
33. Aksoy M, Dincol K, Akgun T, Erdem S. Haemotological effects of chronic benzene poisoning in 217 workers. Br J Ind Med 28: 296-301 (1971).
34. Haves RB, Yin SN, Dosemeci M, Li GL, Wacholder S, Chow WH, Rothman N, Wang YZ, Dai TR, Chao XJ, et al. Mortality among benzene-exposed workers in China. Environ Health Perspect 104: 1349-1352 (1996).
35. Yin SY, Hayes RB, Linet MS, Li GL, Dosemeci M, Travis LB, Li CY, Zhang ZN, Li DG, Chow WH. A cohort study of cancer among benzene-exposed workers in China: overall results. Am J Ind Med 29: 227-235 (1996).
36. Chan C, Spengler JD, Ozkaynak H, Lefkopoulou M. Commuter exposures to VOCs in Boston, Massachusetts. J Air Waste Manage Assoc 41: 1594-1600 (1991).
37. Fleming AF. Benzene in petrol: A continuing hazard. Lancet 336: 1076-1077 (1990).
38. Harrle R. Exposure to methyl tert-butyl ether and benzene among service station attendants and operators. Environ Health Perspect 101(Suppl 6): 23-26 (1993).
39. Infante P, Schwartz E, Cahill R. Benzene in petrol: a continuing hazard. Lancet 336: 814-815 (1990).
40. Jakobsson R, Ahlbom A, Bellander T, Lundberg I. Acute myeloid leukemia among petrol station attendants. Arch Unviron Health 48: 255-259 (1993).
41. Kawai T. Yamaoka K, Uchida Y, Ikeda M, Benzene exposure in a Japanese petroleum refinery. Toxicol Lett 52: 135-139 (1990).
42. Rushton L. Benzene exposure in the petroleum distribution industry associated with leukemia in the United Kingdom: overview of the methodology of a case-control study. Environ Health Perspea 104(Suppl 6): 1371-1374 (1996).
43. Knott D. U.K. unleaded gasoline draws fire in Parliament. Oil Gas J 92: 40-41 (1994).
44. Wallace L. Major sources of exposure to benzene and other volatile organic chemicals. Risk Anal 10: 59-64 (1990).
45. Wallace LA, The Exposure of the General Population to Benzene. Princeton, NJ: Princeton Scientific Publishing, 1989.
46. Midzenski MA, McDiarmid MA, Rothman N, Kolodner K. Acute high dose exposure to benzene in shipyard workers. Am J Ind Me 22: 553-565 (1992).
47. Yin SN, Li Q, Liu Y, Tian F, Du C, Jin C. Occupational exposure to benzene in China. Br J Ind Med 44: 192-195 (1987).
48. Karacic V. Skender L, Prpic-Majic D. Occupational exposure to benzene In ihe shoe industry. Am J Ind Med 12: 531-536 (1987).
49. Fishbein L. Benzene: Uses, Occurrence and Exposure. IARC Monograph on Benzene and Alkylated Benzenes. Vol 10. Lyon: International Agency for Research on Cancer, 1988;67-96.
50. Milla F, Ribera JM, Navarro JT, Granada I, Xandri M, Battle M, Flores A, Junca J, Feliu E. Benzene induced aplastic anemia followed by RAEB after re-exposure, In: Fourth International Symposium on Myeloplastic Syndromes, 24-27 April 1997, Barcelona, Spain. Abstract.
51. Rothman N, Smith MT, Haves RB, Li G-L, Irons RD, Dosimeci M, Haas R, Stillman WS, Linet M, Xi L-Q. An epidemiologic study of early biological effects of benzene in Chinese workers. Environ Health Perspect 105(Suppl 6): 1365-1370 (1996).
52. Koop DR, Laethem CL, Schnier GG. Identification of ethanol-inducible P450 isozyme 3a (P450IIE1) as a benzene and phenol hydroxylase. Toxicol Appl Pharmacol 98: 278-288 (1989).
53. Ross D. Metabolic basis of benzene toxicity. Eur J Haemotol 57(Suppl): 111-118 (1996).
54. Valentine JL, Lee SS, Seaton MJ, Asgharian B, Farns G, Corton JC, Conzalez FJ, Medinsky MA. Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol Appl Pharmacol 141: 205-213 (1996).
55. Snyder R, Hedli CC. An overview of benzene metabolism. Environ Health Perspect 104(Suppl 6): 1165-1171 (1996).
56. Smith MT. Ihe mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia, Environ Health Perspect 104(Suppl 6): 1219-1225 (1996).
57. Wiencke JK, Spitz MR, McMillan A, Kelsey KT. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism. Cancer Epidemiol Biomarkers Prev 6: 87-92 (1997).
58. 609C→T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res 57: 2839-2842 (1997).
59. Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH. Identification of an NAD(P)H: quinone oxidoreductase polymorphism and its association with lung cancer and smoking, Pharmacogenetics 5: 199-206 (1995).
60. Ross D, Traver RD, Siegel D, Kuehl BL, Misra V, Rauth AM. A polymorphism in NAD(P)H: quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity [Letter]. Br J Cancer 74: 995-996 (1996).
61. Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, Ross D. Charaterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer 75: 69-75 (1997).
62. Kastmond DA, Smith MT, Ruzo LG, Ross D. Metabolic activation of phenol by human myeloperoxidase and horseradish peroxidase. Mol Pharmacol 30: 674-679 (1986).
63. Smith MT, Yager JW, Steinmetz KL, Eastmond DA, Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ Health Perspect 82: 23-29 (1989).
64. Subrahmanyam VV, Ross D, Eastmond DA, Smith MT. Potential role of free radicals in benzene-induced myclotoxicity and leukemia. Free Radic Biol Med 11: 495-515 (1991).
65. Piedrafita FJ, Molander RB, Vansant G, Orlova HA, Pfahl M, Reynolds WF. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 271: 14412-14420 (1996).
66. London SJ, Lehman TA, Taylor JA. Mycloperoxidase genetic polymorphism and lung cancer risk. Cancer Res 57: 5001-5003 (1997).
67. Bratton SB, Lau SS, Monks TJ. Evidence for the participation of quinone-thioethers in benzene-mediated hemaiotoxiuiy [Abstract]. Toxicologist 36(1): 165 (1997).
68. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA. Increased risk for myelodysplastic syndromes in individuals with glutathionc transfera.se theta l (GSTT1) gene defect. Lancet 347: 295-297 (1996).
69. Preudhomme C, Nisse C, Hebbar M, Vanrumbeke M, Brizard A, Lai J, Fenaux P. Glutathione S-transferasc theta 1 (GSTT1) gene defects in myelodysplastic syndromes (MDS) and their correlation with karyotype and exposure to potential carcinogens [Abstract]. Leuk Res 21(Suppl 1): S3 (1997).
70. Compton PJ, Hooper K, Smith MT. Human somatic mutation assays as biomarkers of carcinogenesis. Environ Health Perspect 94: 135-141 (1991).
71. Jensen RH, Bigbee WL. Direct immunofluorescence labeling provides an improved method for the glycophorin A somatic-cell mutation assay. Cytometry 23: 337-343 (1996).
72. Mott MG, Boyse J, Hewitt M, Radford M. Do mutations at the glycophorin A locus in patients treated for childhood Hodgkin s disease predict secondary leukaemia? Lancet 343: 828-829 (1994).
73. Rothman N, Haas R, Hayes RB, Li G-L, Wiemels J, Campleman S, Quintana PJK, Xi L-J, Dosimeci M, Titenko-Holland N, et al. Benzene induces gene-duplicating but not gene-inactivating mutations at the glycophorin-A locus. Proc Natl Acad Sci USA 92: 4069-4073 (1995).
74. Tough IM, Court Brown WM. Chromosome aberrations and exposure to ambient benzene. Lancet 7387: 684-685 (1965).
75. Tough IM, Smith PC, Court Brown WM, Harnden DC. Chromosome studies on workers exposed to atmospheric benzene. The possible influence of age. Eur J Cancer 6: 49-55 (1970).
76. Forni A. Chromosome studies in workers exposed to benzene or toluene or both. Arch Knviron Health 22: 373-378 (1971).
77. Forni AM, Canpellini A, Pacifico E, Vigliani EC. Chromosome changes and their evolution in subjects with past exposure to benzene. Arch Environ Health 23: 385-391 (1971).
78. Karacic V, Skender L, Bosner-Cucancic B, Bogadi-Sare A. Possible gcnotoxicity in low level benzene exposure. Am J Ind Med 27: 379-388 (1995).
79. Major J, Jakab M, Kiss G, Tompa A. Chromosome aberration, sister-chromatid exchange, proliferative rate index, and serum thiocyanate concentration in smokers exposed to low-dose benzene. Environ Mol Mutagen 23: 137-142 (1994).
80. Tompa A, Major J, Jakab MG. Monitoring of benzene-exposed workers for genotoxic effects of benzene: improved-working-condition-related decrease in the frequencies of chromosomal aberrations in peripheral blood lymphocytes. Mutat Res 304: 159-165 (1994).
81. Picciano D. Cytogenetic study of workers exposed to benzene. Environ Res 19: 33-38 (1979).
82. Wolman SR. Cytologic and cytogenetic effects of benzene. J Toxicol Environ Health (Suppl)2: 63-8 (1977).
83. Yardley-Jones A, Anderson D, Lovell DP, Jenkinson PC. Analysis of chromosomal aberrations in workers exposed to low level benzene. Br J Ind Med 47: 48-51 (1990).
84. Sasiadek M. Nonrandom distribution of breakpoints in the karyotypes of workers occupationally exposed to benzene. Environ Health Perspect 97: 255-257 (1992).
85. Sasiadek M, Jagielski J, Smolik R. Localization of breakpoints in the karyotype of workers professionally exposed to benzene. Mutat Res 224: 235-240 (1989).
86. Ding XJ, Li Y, Ding Y, Yang HZ. Chromosome changes in patients with chronic benzene poisoning. Chin Med J Engl Ed 96: 681-685 (1983).
87. Forni A. Chromosome changes and benzene exposure. A review. Rev Environ Health 3: 5-17 (1979).
88. Hagmar L, Brogger A, Hansteen IL, Heim S, Hogstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I, et al. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes; Nordic study group on the health risk of chromosome damage. Cancer Res 54: 2919-2922 (1994).
89. Bonassi S, Abbondandolo A, Camurri L, Dal Pra L, De Ferrari M, Degrassi F, Forni A, Lamberti L, lando C, Padovani P, et al. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 79: 133-135 (1995).
90. Le Beau MM. Chromosomal abnormalities in hematologic malignant diseases. In: Progress in Clinical and Biological Research: Mutation and the Environment. Vol 340 (Mendelsohn ML, Albertini RJ, eds). New York: Wiley-Liss, 1990;325-335.
91. Hagemeijer A, Grosveld G. Molecular cytogenetics of leukemia. In: Leukemia (Henderson E, Lister T, Greaves M, eds). Philadelphia: Saunders, 1996;131-144.
92. Kaean J. Molecular biology of chromosomal aberrations in leukemia/lymphoma. Hematol Pathol 7: 159-201 (1993).
93. Look AT. Oncogenic transcription factors in the human acute leukemias. Science 278: 1059-1064 (1997).
94. Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood 86: 3542-3552 (1995).
95. Smith MA, McCaffrcy RP, Karp JE. The secondary leukemias: challenges and research directions. J Nad Cancer Inst 88: 407-418 (1996).
96. Mitelman F, Nilsson PG, Brandt L, Alimena G, Gastaldi R, Dallapiccola B, Chromosome pattern, occupation, and clinical features in patients with acure nonlympnocytic leukemia. Cancer Genet Cytogenet 4: 197-214 (1981).
97. Crane M, Strom S, Halabi S, Berman E, Fueger J, Spitz M, Keating M. Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia. Cancer Epidemiol Biomarkers Prev 5: 639-644 (1996),
98. Forni A, Moreo L. Cytogenetic studies in a case of benzene leukaemia. Eur J Cancer 3: 251-255 (1967).
99. Forni A, Moreo L. Chromosome studies in a case of benzeneinduced erythroleukaemia. Eur J Cancer 5: 459-463 (1969).
100. Sellyei M, Keleman E. Chromosome study in a case of granulocytic leukaemia with 'Pelgerisation' 7 years after benzene pancytopenia. Eur J Cancer 7: 83-85 (1971).
101. Erdogan G, Aksoy M. Cytogenetic studies in 20 patients with pancytopenia and leukaemia with long-term exposure to benzene. In: European and American Division International Society of Hematology, 3rd Meeting, London, 1975. [As cited in Aksoy M. Benzene Carcinogenicity. Boca Raton, FL: CRC Press, 1988.]
102. Erdogan G, Aksoy M. Cytogenetic studies in 20 patients with pancytopenia and leukaemia with long-term exposure to benzene. In: European and American Division International Society of Hematology, 3rd Meeting, London, 1975. [As cited in Aksoy M. Benzene Carcinogenicity. Boca Raton, FL: CRC Press, 1988.]
103. Van den Berghe H, Louwagie A, Broeckaert-Van Orshoven A, David G, Verwilghen R. Chromosome analysis in two unusual malignant blood disorders presumably induced by benzene. Blood 53: 558-566 (1979).
104. Xi L, Zhang L, Wang Y, Smith MT. Induction of chromosome-specific aneuploidy and micronuclei in human lymphocytes by metabolites of 1,3-butadiene. Carcinogenesis 18: 1687-1693(1997).
105. Eastmond DA, Pinkel D. Detection of aneuploidy and aneuploidy-inducing agents in human lymphocytes using fluorescence in situ hybridization with chromosome-specific DNA probes. Mutat Res 234: 303-318 (1990).
106. Cremer T, Lichter P, Borden J, Ward DC, Manuelidis L. Detection of chromosome aberrations in metaphasc and interphase tumor cells by in situ hybridization using chromosomespecific library probes. Hum Genet 80: 235-246 (1988).
107. Gray JW, Pinkel D, Brown JM. Fluorescence in situ hybridization in cancer and radiation biology. Radiat Res 137: 275-289 (1994).
108. Eastmond DA, Schuler M, Rupa DS. Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells. Mutat Res 348: 153-162 (1995).
109. Goldstein BD. Benzene toxicity. Occup Med 3: 541-554 (1988).
110. Rothman N, Li G-L, Dosimeci M, Bechtold WM, Marti GE, Wang Y-Z, Linet M, Xi L-Q, Lu W, Smith MT, et al. Hematotoxicity among Chinese workers heavily exposed to benzene. Am J Ind Med 29: 236-246 (1996).
111. Erdogan G, Aksoy M. Cytogenetic studies in thirteen patients with pancytopenia and leukaemia associated with long-term exposure to benzene. New Istanbul Contrib Clin Sci 10: 230-247 (1973).
112. Zhang L, Venkatesh P, Creek ML, Smith MT. Detection of 1,2,4-benzenetriol induced aneuploidy and microtubule disruption by fluorescence in situ hybridization and immunocytochemistry. Mutat Res 320: 315-327 (1994).
113. Kastmond DA, Rupa DS, Hasegawa LS. Detection of hyperdiploidy and chromosome breakage in inrerphase human lymphocytes following exposure to the benzene metabolite nydroquinone using multicolor fluorescence in situ hybridization with DNA probes. Murat Res 322: 9-20 (1994).
114. Zhang L, Rothman N, Wang Y, Hayes RB, Bechtold W, Venkatesh P, Yin S, Wang Y, Dosemeci M, Li G, et al. Interphase cytogenerics of workers exposed to benzene. Environ Health Perspcct 104(Suppl 6): 1325-1329 (1996).
115. Zhang L, Rothman N, Wang Y, Haves RB, Yin S-N, Li G-L, Smith MT. Aneuploidy of chromosomes 7, 8 and 9 detected by fluorescence in situ hybridization in workers exposed to benzene [Abstract]. In: 86th Annual Meeting, American Association for Cancer Research, 18-22 March 1995, Toronto, Ontario, Canada. Proc Am Assoc Cancer Res 36: 112 (1995).
116. Smith MT, Zhang L, Wang Y, Hayes RB, Li G, Weimels J, Dosemeci M, Tittenko-Holland N, Xi L, Kolachana P, Yin S, Rothman N. Increased translocatlons and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res (in press).
117. Zhang L, Rothman N, Wang Y, Haves RB, Li G-L, Dosemeci M, Yin S-N, Kolachana P, Titenko-Holland N, Smith MT. Benzene exposure is associated with increased aneusomy and long arm deletion of chromosomes 5 and 7 in Chinese workers. In: 88th Annual Meeting: American Association for Cancer Research, 12-16 April 1997, San Diego, California. Proc Am Assoc Cancer Res 38: 123 (1997).
118. Downing JR, Head DR, Curcio-Brint AM, Hulshof MG, Moironi TA, Raimondi SC, Carroll AJ, Drabkin HA, Willman C, Theil KS, et al. An AML1/KTO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translation. Blood 81: 2860-2865 (1993).
119. Liu Y, Hernandez AM, Shibata D, Cortopassi GA. BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci USA 91: 8910-8914 (1994).
120. van Rhee F, Kasprzyk A, Jamil A, Dickinson H, Lin F, Cross NC, Galvin MC, Goldman JM, Seeker-Walker LM. Detection of the BCR-ABL gene by reverse transcription/polymerase chain reaction and fluorescence in situ hybridization in a patient with Philadelphia chromosome negative acute lymphoblastic leukaemia. Br J Haematol 90: 225-228 (1995).
121. Nararajan AT, Boei JJ, Darroudi F, Van Diemen PC, Dulout F, Hande MP, Ramalho AT. Current cyrogenetic methods for detecting exposure and effects of mutagens and carcinogens. Environ Health Perspect 104(Suppl 3): 445-448 (1996).
122. Biernaux C, Loos M, Sels A, Huez G, Stryckmans P. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86: 3118-3122 (1995).
123. National Research Council. Environmental Epidemiology: Public Health and Hazardous Waste. Report. Vol 1. Washington: National Academy Press, 1991.
124. Knox KG. Leukaemia clusters in childhood: geographical analysis in Britain. J Epidemiol Community Health 48: 369-376 (1994).
125. Bithell JF, Draper GJ. Apparent association between benzene and childhood leukaemia: methodological doubts concerning a report by Knox. J Epidemiol Community Health 49: 437-439 (1995).
126. Knox EG, Gilman EA. Hazard proximities of childhood cancers in Great Britain from 1953-80. J Epidemiol Community Health 51: 151-159 (1997).
127. Alexander FE, Leon DA, Carrwright RA. Isolation, car ownership, and small area variation in incidence of acute lymphoblastic leukaemia in children. Paediatr Perinat Kpidemiol 10: 411-417 (1996).
128. van Steensel-Moll HA, Valkenburg HA, van Zanen GE. Childhood leukemia and parental occupation. A register-based case-control study. Am J Epidemiol 121: 216-224 (1985).
129. Shu XO, Gao YT, Brinton LA, Linet MS, Tu JT, Zheng W, Fraumeni JF Jr. A population-based case-control study of childhood leukemia in Shanghai. Cancer 62: 635-644 (1988).
130. Buckley JD, Robison LL, Swotinsky R, Garabrant DM, LeBeau M, Manchester P, Nesbit ME, Odom L, Peters JM, Woods WG, et al. Occupational exposures of parents of children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study Group. Cancer Res 49: 4030-4037 (1989).
131. McKinney PA, Alexander FE, Cartwrieht RA, Parker L. Parental occupations of children with leukaemia in west Cumbria, north Humberside, and Gateshead. Br Med J 302: 681-687 (1991).
132. Kishi R, Katakura V, Yuasa J, Miyake H. Association of parents' occupational exposure to cancer in children: a case-control study of acute lymphoblastic leukemia. Sangyo Igaku 35: 515-529 (1993).
133. Ford AM, Ridge SA, Cabrera ME, Mahmoud H, Steel CM, Chan LC, Greaves M. In utero rearrangements in the trithoraxrelated oncogene in infant leukaemias. Nature 363: 358-360 (1993).
134. Ford AM, Pomuo-de-Qliveira MS, McCarthy KP, MacLean JM, Carrico KG, Vincent RF, Greaves M. Monoclonal origin of concordant T-cell malignancy in identical twins. Blood 89: 281-285 (1997).
135. Savirz DA, Whelan EA, Kleckner RC. Effect of parents occupational exposures on risk of stillbirth, preterm delivery, and smallfor-gestational-age infants. Am J Epidemiol 129: 1201-1218 (1989).
136. Skalko RG. Reproductive and developmental toxicity of the components of gasoline. Environ Health Perspect 101(Suppl 6): 143-149 (1993).
137. Ji BT, Shu XO, Linet MS, Zheng W, Wacholder S, Gao YT, Ying DM, Jin F. Paternal cigarette smoking and the risk of childhood cancer among offspring of nonsmoking mothers. J Natl Cancer Inst 89: 238-244 (1997),
138. Kessler II, Lilienfeld AM. Perspectives in the epidemiology of leukemia. Adv Cancer Res 1 2: 225-302 (1969).
139. Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB. Greaves MF. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots, Proc Natl Acad Sci USA 94: 13950-13954 (1997).